• Obesity Can Improve Overall Survival in Late-stage Prostate Cancer Patients But Not Disease Outcomes, Study Finds
  • Arranon Add-on Improves Long-term Outcomes in Young Patients with T-cell Cancers, Trial Shows
  • Herceptin Treatment Time Could be Halved for Breast Cancer, Phase 3 Trial Finds
  • Update on Apealea, Potential Ovarian Cancer Therapy, Set for ASCO 2018 in June
  • When the Impossible Becomes Possible
  • My Crohn’s Flare and Hospital Stay Led to Blood Clots
  • Medication Side Effects: Necessary Evils
  • Reclaiming Joy on Difficult Days with Pulmonary Fibrosis
  • MS News that Caught My Eye Last Week: PML Treatment, Gilenya for Kids, Rituximab, and an MS trial that is Enrolling
  • Fat-Derived Stem Cells a Potential Safe, Feasible Treatment for Secondary Progressive MS, Trial Shows
  • Veracyte Launches Early Access Program for Envisia Genomic Classifier Test to Improve IPF Diagnosis
  • Gut Microbiome May Offer Way to Ease or Halt Brain Inflammation, Study Suggests